Sign In

Morgan Moncada

MBA/MS Biotech Candidate at Harvard - VP Ops, Co-MD Boston Chapter at Nucleate - Longevity, SynBio, Data Science - Stanford alum

Morgan Moncada is a notable figure in the health technology sector, currently serving as the Co-Managing Director for the Boston branch and Vice President of Operations at Nucleate. She is also recognized as the CEO and co-founder of Willow Health, an AI platform focused on holistic brain health monitoring and intervention. Moncada's expertise lies in integrating artificial intelligence with healthcare solutions, which is reflected in her leadership roles and entrepreneurial ventures.

She recently gained recognition as a 2023-2024 Blavatnik Fellow at Harvard Business School, a program designed to support entrepreneurs in the life sciences field. This fellowship allows participants to develop new ventures around promising life science technologies while receiving mentorship and professional development opportunities.12 Moncada holds a strong educational background, having completed her MS/MBA at Harvard Business School and a Bachelor's degree in Biology from Stanford University.

Her professional journey highlights her commitment to advancing health technology and her role in shaping future innovations in the biomedical industry.

Highlights

Jul 6 · hbs.edu
Harvard Business School Announces Its 2023-2024 Blavatnik Fellows

Related Questions

What is Morgan Moncada's role at Nucleate?
How did Morgan Moncada transition from Harvard Business School to her current position?
What are some of Morgan Moncada's notable achievements in the healthtech industry?
What is the focus of Morgan Moncada's work at Willow Health?
How has Morgan Moncada's experience at Moderna influenced her career?
Morgan Moncada
Morgan Moncada, photo 1
Morgan Moncada, photo 2
Add to my network

Location

San Francisco Bay Area